Skip to content
Free shipping in Norway · 100-day exchange and returns
Circadian Eyewear
Country and language EnglishNOK
Country and language

Language

Country and currency

0 items in cart

Cart

Your cart is empty.

Research

What the research says

Light in the evening affects when your body gets ready for sleep. That part is well established. How much glasses that filter this light improve sleep is still being studied, and results differ between groups. Here is the research we follow, with what each study found.

Diagram of how much light the ORPHEUS lens lets through at each wavelength, blocking blue and green light below 520 nm

In short

Well established

Blue and green light in the evening holds back melatonin and shifts the body clock later.

Measured in trials

Strongly tinted orange lenses worn in the evening let melatonin rise earlier.

Promising, not settled

Several trials report faster sleep onset in people with sleep problems. Trials in healthy sleepers show small or no effects.

Still open

Long-term effects, and which groups benefit most.

Research that used our glasses

Chosen for hospital research

Researchers at St. Olavs Hospital and NTNU used Circadian Eyewear glasses in a trial with 476 patients in acute psychiatric care, published in PLOS Medicine in 2024. The trial compared a ward with blue-depleted evening lighting with a ward with standard lighting. Patients who left the blue-depleted ward in the evening were offered our glasses, so they stayed shielded from blue light outside it.

Patients in the blue-depleted ward improved more and showed less aggressive behaviour. Length of stay was the same. The trial tested the light environment as a whole, not the glasses on their own.

Kallestad and colleagues, PLOS Medicine, 2024

Many other hospitals and health clinics in Norway have bought Circadian Eyewear glasses, for research and for use with their patients. Published studies do not always say which glasses were used, so our glasses may be part of more research than we can list here.

The entrance and interior of the psychiatric ward at St. Olavs Hospital in Trondheim, lit in orange in the evening
The entrance and interior of the psychiatric ward at St Olavs in Trondheim, Norway, where blue wavelengths are removed in the evening. Photograph: Trondheim Sleep Group/St Olav's hospital

Reviews of many studies

Source What it found
Frontiers in Neurology, 2025 Pooled three crossover trials with 49 adults. Small sleep improvements that did not reach statistical significance. Calls for larger trials.
Review of blue-blocking filters, 2025 Results depend on how much light the lens removes. Argues the name should be kept for lenses that filter short wavelengths strongly.
Chronobiology International, 2021 Reviewed 29 experimental publications. Found substantial evidence for shorter time to fall asleep in people with sleep disorders, jet lag or shift work.
Shechter and colleagues, meta-analysis Orange and amber lenses before bedtime may improve sleep, mainly in people prone to sleep problems.

Clinical trials in Norway

Researchers at the University of Bergen and Haukeland University Hospital have run several controlled trials with orange blue-blocking glasses.

Source What it found
Pregnancy and melatonin, 2021 60 women in the third trimester. Melatonin rose 28 minutes earlier in the evening with blue-blocking glasses than with control glasses.
Pregnancy and sleep, PLOS ONE, 2022 The same 60 women. No statistically significant difference in sleep between the two groups.
Hospital trial in bipolar mania, 2020 Patients admitted to hospital wore the glasses in addition to their standard treatment. Symptoms fell faster than with clear glasses. A small study in a specialist setting. A later Canadian trial with blinded raters did not reproduce the result.
Insomnia in psychiatric care, ongoing Tests group therapy for insomnia with blue-blocking glasses as an add-on. Planned completion December 2026.

The ORPHEUS lens in numbers

  • 99%

    of light below 520 nm is blocked.

  • Over 90%

    of light above 635 nm passes through, so you can still read and use screens.

  • 32%

    luminous transmittance, tested to the ISO standard (pass).

  • Class 1

    medical device under EU rules. The lens is tested by the Norwegian Radiation and Nuclear Safety Authority.

These studies were carried out by independent researchers. Published studies do not always name the glasses they used, so we only say a study used Circadian Eyewear glasses where we can confirm it, as with the St. Olavs trial above.

Our glasses are not a treatment for any illness. If you have a sleep disorder or a medical condition, talk to your doctor.